Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection

We explores the accuracy and sensitivity of rapid intraoperative detection of IDH, TERT, BRAF indicators through a prospective clinical multi-center study. This part includes a total of 300 fresh tissue samples, paired blood samples, relevant clinical information and follow-up information from 300 patients with different grades of adult glioma. By comparing with the postoperative sequencing results, the specificity and sensitivity of intraoperative IDH and TERT rapid detection results are clear.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glioma, Malignant Glioma Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neoplasms, Neuroepithelial Neuroectodermal Tumors

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

1. Glioma patients with Informed Consent Form 2. Glioma patients with intact clinical information

Exclusion criteria

1. Glioma patients without Informed Consent Form 2. Glioma patients without intact clinical information

Treatment and study plan

Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Diagnostic Test

Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Primary outcomes

Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Time frame: Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Sponsors and collaborators

Lead sponsor

Jinsong Wu

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: May 27, 2021
Registry last updated: Apr 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed